Aspects of Renal Disease Affecting Dental Management — Surgery in Patients Receiving Hemodyalisis by Dencheva, M. et al.
Selection of our books indexed in the Book Citation Index 
in Web of Science™ Core Collection (BKCI)
Interested in publishing with us? 
Contact book.department@intechopen.com
Numbers displayed above are based on latest data collected. 
For more information visit www.intechopen.com
Open access books available
Countries delivered to Contributors from top 500 universities
International  authors and editors
Our authors are among the
most cited scientists
Downloads
We are IntechOpen,
the world’s leading publisher of
Open Access books
Built by scientists, for scientists
12.2%
122,000 135M
TOP 1%154
4,800
Chapter 7
Aspects of Renal Disease
Affecting Dental Management —
Surgery in Patients
Receiving Hemodyalisis
M. Dencheva, E. Deliverska, A. Krasteva,
J. Galabov and A. Kisselova
Additional information is available at the end of the chapter
http://dx.doi.org/10.5772/59930
1. Introduction
Kidneys play several roles in helping maintain physiologic balance; they are therefore
important for continuing or regaining homeostasis during and after surgery and anesthesia.
The renal system is necessary to support the processes of fluid, electrolyte, and acid-based
balance, drug metabolism and elimination, blood pressure control through the renin-angio‐
tensin system, red blood cell production through erythropoietin production, and vitamin D
hydroxylation.
2. Main issues regarding the oral health in patients on hemodialysis and
those with kidney transplant
The primary role of the dental doctor consists of the early diagnosis or referral of the patient
to the right specialist, as the most frequent renal disease a dentist may encounter is the chronic
kidney disease [18, 39, 114].
The symptoms that may lead us to the conclusion of constrained renal function vary depending
on the extent of the damage and the reaction to the suggested treatment, and are characterized
with systemic as well as intraoral findings.
© 2015 The Author(s). Licensee InTech. This chapter is distributed under the terms of the Creative Commons
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3. Common symptoms at CKD (Chronic Kidney Disease)
Disease Symptoms
Gastrointestinal – nausea, vomiting, anorexia, metal taste, malodor, oesophagitis, gastritis, gastrointestinalbleeding
Neuromuscular – headache, peripheral neuropathy, paralysis, sleep disturbances, numbness of limbs,convulsions correlating with level of the azotemia
Hematoimmunologic – normocytic and normochrome anemia, coagulopathy, low resistance to infections, lowproduction of erythropoietin, lymphocytopenia
Endocrine metabolic – renal osteodystrophy (osteomalacia, osteosclerosis, fibrous cysts), secondaryhyperparathyroidism, disturbed growth, decreased libido, amenorrhea, thyroid dysfunction
Cardio vascular – cardiomyopathy, arrhythmia, pericarditis, high blood pressure, difficulty in breathing,congestive heart failure
Dermatologic
– paleness, itching, signs of scratching because of the itch, increased photosensitive
pigmentation, uremic white spots, brown coloring of the nails- Fig.1, signs of water retention,
limb heaviness, edema of the ankles
Respiratory – Kussmaul breathing because of acidosis, pulmonary edema, dyspnea
Table 1. Symptoms at CKD [18, 125]
Figure 1. Brown coloring of nails
Renal osteodystrophy or renal bone disease is one of the most prominent signs of CKD and
may occur in one or several combined forms. As a result of the increase of the level of phos‐
phates in blood plasma, the decrease of calcium in blood plasma and the failure of processing
of 25-hydroxycholecalciferol into the active and necessary 1.25 dihydroxycholecalciferol, an
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increase of the parathormone (PTH) occurs. This leads to secondary hyperparathyroidism.
Because of the increase of the non-mineralized bone matrix progressive bone changes may be
observed - osteomalacia, lytic lesions followed by bone fibrosis. Renal osteodystrophy in kids
leads to a delay in skeletal growth and a tendency for spontaneous fractures.
Most frequent orofacial signs of renal osteodystrophy are bone demineralization, lower
trabeculation, lower density of the cortical bone, calcifications in soft tissues, radiolucent
fibrocystic lesions, and complicated bone healing following extraction. Regarding the teeth
and parodontal tissues we may observe delayed eruption, enamel hypoplasia (fig.2), loss of
lamina dura, widening of the periodontal space, severe periodontal destruction, tooth
mobility, denticles, obliteration of pulp chamber, and giant-cell lesions of the type “brown
tumors”[78, 85].
 
Figure 2. Hypoplasia and open bite in a female patient on hemodialysis
Nephrotic  syndrome  is  observed  in  patients  with  glomerular  diseases.  It  includes  pro‐
teinuria  (over  3.5  gr),  hypoalbuminemia,  hyperlipidemia,  lipiduria,  and  edema.  Causes
may vary:  sugar  diabetes,  chronic  lupus erythematosus,  or  membrane glomerulonephri‐
tis.  Increased  level  of  blood  coagulation  factor  VIII  may  lead  to  hypercoagulation  and
increased  risk  of  thrombosis.  Such  patients  may  suffer  catabolic  processes,  bacterial,
fungal  and  viral  infections  [53,  66].
It should be noted that a significant part of the patients with renal disorders may also suffer
from diabetes [14]. It is less probable for a dentist to diagnose diabetes, but patients whose
dental status alters unexpectedly as rapidly as in progressive parodontitis, fungal eczemas,
abscesses, high fluid intake, rapid weight loss, mouth dryness and halitosis [28, 29] may be
suspicious. Those symptoms impose the appointment of definite examinations, which may
help to set the latter diagnosis.
Renal disorders almost invariably cause anemia as a result of the kidneys’ inability to produce
erythropoietin. Fibrosis of marrow and the increased loss of erythrocytes are additional factors
which increase the development of the disease. Anemia leads to fatigue, loss of concentration,
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tissue hypoxia, and paleness of the oral mucosa. In patients with advanced and untreated
uremia, yellow-brownish coloring of the skin and mucosa because of the accumulation of
carotene-like substances [4, 125] may be observed.
4. Intraoral findings typical for patients on hemodialysis and patients with
kidney transplant
• Almost mandatory findings for each patient on hemodialysis are uremic breath and altered
taste in the oral cavity. They occur as a result of the increased concentration of urea in saliva
and its following transformation to ammonia [18, 60, 113, 121]. It is possible, however, for
similar complaints to be registered in patients with normal values for blood and urine, for
example after transplantation, and this is caused by the higher corrosion potential, combined
with insufficient and personal and professional oral hygiene [90].
• Xerostomia could be explained with lowered fluid intake, as a side effect of antihypertensive
or other medicaments, possible alterations in the salivary glands due to autoimmune or age-
related changes [25, 26, 27, 28, 41, 47, 52, 73, 91, 92]. The study of Bots et al. [12] proves that
in patients on hemodialysis the saliva quantity (stimulated and non-stimulated) is tempo‐
rarily lowered but after transplantation and recovery of the renal function it is restored to
normal values. With the same patients they register drop in pH from 7.36 to 6.74 probably
because of the lower concentration of urea in saliva and the following decrease of hydrolysis
and by the transformation of oral flora to ammonia [16].
• Oral mucosa findings, reported in patients with CKD, with the exception of uremic stoma‐
titis (fig.3), are unusual and vary, as a result of the main disease, as well as the intake of
drugs: white plaques, macules, nodules, erythematous plaques, fibro-epithelial polypus,
ulceration, geographic tongue (fig.4), lichen planus, red fibrous tongue, fiber leukoplakia,
and papilloma [21, 38, 76]. We may notice pale oral mucosa because of anemia, but also red-
orange coloring of the skin following the deposition of carotene-like substances [71, 92, 110].
Cervero et al. [18] described 4 types of uremic stomatitis (erythematous, ulcerative, haemor‐
rhagic and hyperkeratotic). The lesions are painful, situated on the ventral surface of the
tongue, on the floor of the oral cavity and the buccal mucosa. Most frequently the cause is
untreated CKD. It emerges because of inflammation and the chemical influence of ammonia
or ammonia components, formed by the hydrolysis of the urea (over 30mmol/L intraoral) [95]
in the saliva by urease. Kellet [58] reports about four patients with chronic renal insufficiency
suffering white painless plaques. They are not subject to treatment, and they disappear in up
to 2 or3 weeks after regulating the level of blood urea. Long [71] defines two types of uremic
stomatitis: І type - generalized or localized erythema with grey-white pseudomembrane
coating the removal of which doesn’t lead to bleeding or ulceration, and type ІІ- after removing
the coating of the surface is ulcerating [3, 27, 58, 71].
Updates in Hemodialysis116
Uremic stomatitis, whitish-gray pseudomembranesFigure 3. Uremic stomatitis
Figure 4. Geographic tongue
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• Mac-Donald [74], Peneva et al. [87] found delay in the eruption of the permanent teeth with
statistically significant difference in children born with the disease and lasting for life in
comparison to healthy children.
Peneva et al. [85] explored the incidence of tooth decay among 30 children on hemodialysis
and defined that children on dialysis suffer less frequently from decay compared to healthy
children. They also found that, decay resistance is higher at children with earlier beginning of
the disease and longer duration.
Shu et al. [105] explored the correlation between decay and urease activity of the tooth plaque
in 25 caries-free participants and 8 participants with decays. They found that in the caries-free
subjects urease activity of the dental plaque is significantly higher than this in patients with
caries. They suggested that the loss of alkalizing potential of the tooth biofilm is in positive
correlation with the incidence of tooth decay. Meanwhile they didn’t establish statistically
significant difference in the salivary urease activity.
• Takeuchi et al. [111] researched the oral microbial flora in patients with renal disease and
its influence on caries and parodontal pathology. They discovered significantly higher count
of parodontal and decay pathogens in patients with renal disease. This fact in turn defines
the higher risk of tooth decay and parodontal disease compared to healthy samples.
Most researches regarding the oral status of patients with CKD, on hemodialysis or trans‐
planted, are made with a control group consisting of healthy patients. For the first time a long-
term, two- year research by Bots et al. [13] compares xerostomia, the sense of thirst, saliva
secretion and the general oral health of patients with renal failure to those of a group of
transplanted patients. Using DMFT, DMFS- indexes they find that the teeth affected by decay
don’t differ statistically in the group of patients on hemodialysis from those of the control
group with transplanted patients. In this research, the scholars expressly note the increased
necessity of examining the oral status of patients expecting transplantation.
Gavalda et al. [41] examined 105 patients on hemodialysis. They diagnosed mucosal, salivary,
dental and periodontal findings in the oral cavity. They didn’t find significant difference
between the value of the index referring to the decay incidence in patients on hemodialysis
and healthy samples, but they established such at indexes reflecting the amount of calculus
and tooth plaque.
Bayraktar et al. [8] found elevated incidence of tooth caries in their control healthy group
compared to group of patients on hemodialysis, but that rise is not statistically significant.
Rustemeyer et al. [97] didn’t find statistically significant difference of the dental health of the
groups in their research either, but they noted the tendency for higher value of DMFT in the
groups expecting renal transplantation ( =14,9), liver transplantation ( =14,5), valve transplan‐
tation ( =15,2) and the control group ( =13,8).
In the scientific literature, the issue of prevention and early dental intervention in patients on
dialysis has become extremely pertinent, with a marked emphasis on the requirement for an
interdisciplinary approach towards these patient groups [11, 30, 61].
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Hypoplasia- there are cases where ESRD evolved in childhood. Pulp obliteration is due to
violations in calcium and phosphoric exchange [60, 74, 81, 86, 90].
1. It’s been proven that parodontitis may contribute to the development of common
inflammation processes and systemic diseases such as atherosclerosis and cardiovascular
diseases [22, 109]. Gingival pathogens may damage system circulation in the body by one
of two connected mechanisms:
2. They provoke liver enzyme activity, influencing IL-6 and C-reactive protein, which in its
turn activates the system of the complement and cause the deposition of calcium connec‐
tions and aggregation of LDL and very LDL cholesterol.
3. P. gingivalis damages human endothelial cells and helps the formation of atheromatous
plaques [11, 22, 60, 65, 84, 112].
Fisher [37] in his research defines parodontal disease as an “unconventional risk factor for the
development of chronic renal disease”. Pejcic et al. [84] took part into the discussion about the
role of periodontitis as a risk factor for general diseases. Authors such as Klassen and Krassko
[62] and Al Wahadni and Al Omari [2] report prevalence of gingival and parodontal diseases
in patients on hemodialysis. There are authors who don’t find increase in parodontal indexes
with such patients [13, 55, 81]. Kshisageret et al. [68] note the significance of parodontal health
in end-stage renal failure. They carried out a retrospective cohort research and followed the
correlation between parodontal diseases and the mortality rate of patients with severe
cardiovascular disease, such as patients with CKD. They established define that the mortality
rate in the group of the patients with medium to severe periodontitis and cardiovascular
disease is five times higher for the 18- month period of the research.
Using parodontal diagnostics, that includes CPITN, PI, PBI (papillary bleeding index), CAL
(clinical attachment level), Borawski et al. examine patients on hemodialysis, patients on
peritoneal dialysis, patients in the pre-dialysis stage, patients with advanced periodontitis and
average patients (randomly selected). The research shows a much higher incidence of paro‐
dontitis development in patients with renal disease in comparison to average patients.
Periodontal disease is practically most severe in patients on hemodialysis, less severe in
patients on peritoneal dialysis and moderate in patients in the pre-dialysis stage.
Relatively little is known about the long term effect of dialysis treatment on oral health. A
research carried out by a group of Turkish scientists, Bayraktar et al. [8], proves the necessity
of sanitation, because of the negative results that occur with time onto oral health of this patient
group. The publications of Graig [44], Donald [31], and Davidovich [23, 24] testify to the two-
way relation between end-stage CKD and the severity of parodontal inflammation, which can
be proved by examining the levels of C-reactive protein.Bayractar et al. [8], led by the fact that
problems with oral health may have a negative influence over patients in end-stage CKD,
launched a survey comparing the parodontal and dental status of patients with renal failure
and a healthy control group. They established that there isn’t a statistically significant differ‐
ence between the measured pocket depths (PPD) of the two groups, but the values of the plague
index (PI), the calculus index (CSI), and the gingival index (GI) show significant statistical
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difference. A positive correlation was established between the duration of dialysis procedures
more than 3 years and missing teeth, the gingival index and pocket depth.
The research of Davidovich [24] shows for the first time the relation between the duration of
dialysis and parodontal diseases in children. The results present a significant loss of epithelial
attachment in patients with end-stage CKD compared to healthy patients. A positive correla‐
tion was established between the severity of parodontal status and bad oral hygiene, the uremic
status, and the duration of the kidney disease.
• Regarding the cause of commonly reported gingival inflammation in patients with CKD,
controversial data in literature exists. Nunn et al. [81], Tollefsen & Jonasen [118, 119], and
Ertugrul et al. [36] report reduction in gingivitis because of immunosuppressants and
uremia. Naugle et al. [79] reveal conflicting data. Furthermore, Kitsou et al. [62] reproduce
experimental gingivitis following the protocol of Löe. Oral hygiene is discontinued for 28
days. The authors report they haven’t found differences in the gingival indexes between the
group of 6 patients on hemodialysis and one of 6 patients without renal problems and
conclude that chronic uremia doesn’t contribute to the defensive mechanisms of parodontal
tissue against tooth plaque. Davidovich et al. [24] report a statistically significant difference
comparing the duration of the dialysis and CKD and gingival and parodontal changes. They
report that uremia and immunosuppression reduce but don’t eliminate an inflammation
response of the gingiva and periodontium against tooth plaque. Another condition accom‐
panying end-stage renal failure is diabetes. Chuang et al. [21] compared the oral health of
45 patients suffering from diabetes and undergoing hemodialysis treatment to that of 83
patients without diabetes but on hemodialysis. They reported lower saliva secretion and
lower pH connected with higher caries levels in the diabetes group, but they didn’t observe
differences in gingival inflammation and the presence of parodontitis. In the research of
Borawski et al. [11] the need is noted of treatment through CPITN for patients on hemo‐
dialysis and transplanted renal patients.
Figure 5. Cyclosporine induced gingival hyperplasia
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• Another finding in patients with end-stage liver failure, is drug-induced gingival hyper‐
plasia (DIGH) (fig.5). Its mechanism of occurrence is multifactorial and has not yet been
fully explained. The intake of antihypertensive and immunosuppressive drugs gives
evidence in the oral cavity [42, 50, 104, 115]. Such overgrowth is usually observed in the
early posttransplantation period (4 m) and in combination with insufficient oral hygiene or
previously damaged periodontium [1, 30, 89, 112].The sole influence of cyclosporine
remains controversial in the specialized literature. Data varies from 25 to 81% depending
on methods used [104]. R. A. Seymour [103] compares the influence of azathioprine on
gingiva to that of cyclosporine and finds that azathioprine has no damaging effect on the
gingiva. J. A. James [57] reports the absence of gingival changes when using tacrolimus
(6,4%) and cyclosporine (17,9%) on the third month after immunosuppression, excluding
patients with accompanying antihypertensive therapy. Their study shows that tacrolimus
also induces gingival hyperplasia, but to a lesser extent [3]. James [56] takes into consider‐
ation 4 cases of swapping cyclosporine with tacrolimus, combined with professional care of
periodontist. In only one case a full regression of the gingival overgrowth occurs. J. A. James
[57] compares gingival hyperplasia among 25 patients taking tacrolimus, and 26 control
group patients and doesn’t find a statistically significant difference. This gives him the
grounds to distinguish tacrolimus as an alternative to cyclosporine A, when a severe case
of gingival hyperplasia is present.
Researches made by Davidovich [24] and Thorp et al. 116] confirmed the findings of Nunn et
al. [81] about gingival overgrowth in transplanted patients on immunosuppression with
cyclosporine A and less frequently occurring one in patients taking tacrolimus.
Radwan- Oczko et al. [94] sought a connection between gingival hyperplasia, immunosup‐
pressive drugs and the growth factor β1 (TGF β1), which is considered a key cytokine in
fibrogenesis. They didn’t prove any statistically significant relation between gene expression
of TGF β1, gingival hyperplasia and treatment with cyclosporine A and tacrolimus.
Djemileva [30] and Gera [42] believe that shared responsibility in maintaining oral health in
the long process of treatment of these patients is a crucial factor as well as the possible switch
of immunosuppressants. The studies of Somacarrera et al. [108], Ellis et al. [34], and J. Smith
et al. [106] are taken as evidence corroborating the supposition that maintaining sufficient oral
hygiene leads to a decrease of gingival hyperplasia.
• Malignancy. The suppression of the immune system in transplanted patients may predis‐
pose the formation of malignant entities. Two types of malignant formations that prevail in
patients with kidney transplantation have been reported: cancer of the cervix and squamous
cancer of the skin [10, 17, 66, 88, 100]. Malignancy may also include Kaposi’s sarcoma, renal
cancer, and lymphomas.
• Candidiasis is particularly specific for the early post-transplantation period: from 0 to 6
months. It is caused first by the immunosuppressive action of the drugs and the impact on
oral homeostasis and second by the decrease of saliva secretion- medications for hyperten‐
sion, and dialysis procedures [32, 49, 78, 99].
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4.1. A dental treatment approach to patients on hemodialysis and transplanted
Assuming susceptibility of the patients on hemodialysis and those with a renal transplant to
infections, it proves necessary to pick the right antibiotics for each dental procedure, that may
cause longer bacteraemia [97, 120]. A number of studies prove the need of antibiotic protection
at risky dental manipulations, even though according to Lockhart et al. [70], washing one’s
teeth is comparable to tooth extraction as a possible cause for bacteraemia [122, 123]. It’s
necessary to have in mind the possibility of contamination of parodontal tissues through
various means of personal oral hygiene [72, 93].
The American Heart Association in its recommendations for the prevention of bacterial
endocarditis from 2007 [123] divides the dental procedures into such hazardous for bacterae‐
mia: all procedures connected with manipulation of the gingival tissue and the periapical
region of the teeth, or perforation of the oral mucosa, and these where antibiotic prophylaxis
is not necessary: routine anesthesia through non-infected tissue, radiographs, and bleeding
from trauma of the oral mucosa. In a similar way, D. Tong [119, 120] made a division of the
dental procedures (table 2).
High risk category
Tooth extraction
Periodontal procedure that includes surgery, Ultrasound scaling
Root probing
Implant placing and tooth reimplantation
Endodontic instrumentation or surgery beyond root apex
Subgingival application of antibiotic fibers and bands
Initial placing of orthodontic rings but not brackets
Intraligamentary local anesthesia
Preventive cleaning of teeth or implants with expected bleeding
Procedures where prophylaxis is not needed
Dental restorations with or without a retraction cord
Local anesthesia (excluding intraligamentary)
Intracanal endodontic procedures after placing implants and build-ups
Rubber dam placing
Post-operative suture removal
Placement of orthodontic and prosthetic constructions
Taking of dental impressions
Teeth fluoridation
Radiographs
Adjustment of orthodontic constructions
Replacement of milk teeth
Table 2. Dental procedures with a compelling antibiotic prophylaxis in patients at risk
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4.2. Dental treatment approaches in the pre- and post-operative periods
i. Most authors are unanimous that in the pre-transplantation period preventive
sanitation of all foci is necessary [5, 6, 11, 12, 27, 46, 64, 82, 84, 96, 97, 98]. To the initial
dental diagnostics that includes standard dental examination and parodontal
examination the methods of the complex oral and focal diagnostics could be added,
which may define the dominant and latent foci that early in the pre-transplantation
period so that a treatment plan for the post-transplantation period can be devised.
Dental doctors should be aware of the degree of renal insufficiency and the current
medical status of the patient. Consultation with the patient’s general doctor should
be made and lab tests should be performed, especially before surgical dental inter‐
ventions. The intake of systemic antibiotics in the pre-transplantation period is
contraindicated [82], not counting life-threatening situations. Heavily damaged
decayed teeth and such with radiograph changes and symptoms should be extracted.
A mass teeth extraction procedure is to be performed on patients with bad oral
hygiene and advanced periodontal disease, and on those unmotivated to maintain
sufficient oral hygiene. Surgical sanitation is followed by prosthetic restoration [54].
It is necessary to treat all newly emerged dental conditions without waiting for the clinical
symptoms to develop. Moreover, to fulfil the requirements for sufficient dental health, a
patient should have a sufficient knowledge. Several studies take notice of the fact that patients
suffering from CKD don’t maintain sufficient oral hygiene and it should be improved [7, 43].
Infection control is a complex issue regarding patients with end-stage renal disease. If an
invasive dental procedure is required, a consultation with the treatment doctor must be made.
The current health status of the patients is consulted, as well as the possible need of antibiotic
premedication, usage of local anesthetics and other drugs. Prescribing medicaments to patients
with renal insufficiency should be approached with care and in full accordance with their
current medical and renal condition [19, 20, 53, 67] (table 3).
Antibiotic Normal renal function Glomerular filtration 10–50ml/min
Glomerular filtration <10
ml/min
Amoxicillin 8 h 8–12 h 12–18
Ampicillin 6 h 6–9 h 9–12
Cephalexin 6 h 6 h 6–12 h
Clindamycin 8 h 8 h 8 h
Doxycycline 12–24 h 12–24 h 12–24 h
Erythromycin 6 h 6 h 6 h
Metronidazole 8 h 8 h 12–16 h
Table 3. Antibiotic premedication for patients suffering from CKD, adap. J. W. Little, D. A. Falace et al [66]; J. A. Ship
[105]
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W. M. Bennett et al. [9] propose a change in dosage for patients on hemodialysis with emerged
tooth infection:
• Penicillin 500 mg p. o. every 6 hours after dialysis;
• Amoxicillin 500 mg p. o. every 24 hours after hemodialysis;
• Ampicillin 250 mg – 1 g p. o. every 12-24 hours after hemodialysis;
• Erythromycin 250 mg р.о. every 6 hours optional only after dialysis;
• Clindamycin 300 mg р.о. every 6 hours optional only after dialysis.
According to data from Tong and Walker [120] in Australia and New Zealand, 53% of dental
doctors follow the instructions of AHA for the prevention of bacterial endocarditis. One of the
most frequently used patterns for premedication is taking a 2g Amoxicillin or 600 mg Clinda‐
mycin (in cases of Penicillin allergy) one hour before a dental procedure: for kids 50mg/kg oral
intake 30-60 minutes before the procedure.
A survey in two Swedish provinces reveals that the most frequently prescribed antibiotics to
kidney transplanted patients when performing scaling, tooth extraction and root canal
treatment are Amoxicillin, Penicillin, Clindamycin [33].
The issue of antibiotic prevention of bacterial endocarditis has undergone considerable
development in the past 10 years. In 2007 AHA published an amendment to the recommen‐
dations from 1997. AHA (2007) narrows significantly the diseases whose dental treatment is
indicative for antibiotic prevention. In the recommendations patients with dialysis shunts are
classified in class 3, level C on account of the possibility for the development of bacterial
endocarditis during dental treatment. This means that there are indications, supported with
evidence or general agreement, that the procedures/treatment are not necessary, ineffective
and in some cases even damaging. The level of evidence is C, in other words the recommen‐
dations are based only on an established consensus of views of experts, on separate cases or
on accepted standards of treatment. Despite this fact, these patients are defined as ‘’unique’’
in view of the higher risk of infections of the venous shunt, because of their immunocompro‐
mised status and the increased count of S. aureus [5]. Around 22% of the arteriovenous shunts
get infected, which leads to antibiotic intake or to changes in the intake plan. The pathogens
linked with the infection occurring in the application of the vascular approach are 53% S.
aureus and 20.3% coagulase-negative staphylococci. In the AHA guide [5] to non-valvular
cardiovascular equipment a regime of antibiotic prophylaxis of patients with hemodialysis
shunts and organ transplants is not mentioned. The same opinion is maintained by Pallsh [83].
Lockhart et al. [69] methodically examine the efficiency of antibiotic premedication in dental
practice. They divide patients taking antibiotics in 8 groups. One of the groups consists of
patients with hemo- and peritoneal dialysis: with kidney dialysis shunts (hemodialysis and
peritoneal). The authors found little or no scientific evidence on issues relating tothe usage of
antibiotic prophylaxis before dental procedures in these 8 groups of patients.
Until now no clear evidence has been provided that during invasive dental treatment of
patients with advanced renal, liver or heart condition antibiotic prevention is needed, but most
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dental centers and authors follow the instructions of the AHA [123], pointing out two main
reasons: shunt infection risk [101] or the possible development of infectious endocarditits [109]
(table 4).
Condition Antibiotic Prescription
Standard prophylaxis Amoxicillin Adults 2.0mg Kids50 mg/kg
Inability for oral intake Ampicillin 2g i.m. or i.v. 50 mg/kg i.m. or i.v.
Penicillin allergy
Clindamycin 600mg 20 mg/kg
Cephalexin* or cefadroxil 2 gr 50 mg/kg
Azithromycin or
Clarithromycin 500 mg 15 mg/kg
Penicillin allergy and inability for oral
intake
Clindamycin 600 mg i.m. or i.v. 20 mg i.m. or i.v.
Cefazolin 1 gr i.m. or i.v. 50 mg/kg i.m. or i.v.
* Or other first or second generation cephalosporins in equivalent doses for adults and children
Table 4. Antibiotic premedication according to AHA’s recommendations
Patients awaiting transplantation undergo antibiotic premedication from the moment they are
moved into the operation theater. The duration of the antibiotic treatment is usually with a
duration of up to 3 days. In the best case scenario the antibiotic intake should be determined
on the basis of the bacterial flora present, the kind of transplantation and patient-specific
features [107]. For example a kidney transplanted patient may be prescribed Cefazolin and
Ampicillin-sulbactam to cope with the uropathogens and staphylococci. In patients with
chronic dental infections, frequent or continuous bacteraemia may occur, which in its turn may
trigger acute or chronic inflammation in other organs [61].
De Rossi and Glick [27] systematize a few guidelines for a recommended dental approach to
patients on hemodialysis. They also follow AHA’s recommendations, but they think that the
antibiotic of choice should be Vancomycin, which must be flowed on the day of the dialysis
before an invasive dental procedure, since its action on the organism lasts for the next 7 days.
What follows is a radical approach with the extraction of the tootth.
With better medical care, the expectations of the patients for better and longer life are justified.
Hemostatic agents
Standard tests for suspected coagulopathy include [45]:
1. Bleeding time (BT).
2. Prothrombin time (PT).
3. Partial thromboplastin time (PTT).
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4. Platelet count (table 8).
5. INR (International Normalised Ratio).
Lockhart et al. [68] define several points which need to be considered before invasive dental
procedure is initiated on patients with CKD. The first issue to consider is the analysis of what
is described above, as well as the influence of the platelet count on the expected post-operative
bleeding (table 5).
Platelet count
(на μl) Diagnose Effect
150 000-450 000
100 000–150 000
Normal
Mild thrombocytopenia Rare but possible operative bleeding
50 000–100 000 Moderate thrombocytopenia Increased possibility for bleeding during dentalmanipulation but unusual.
25 000–50 000 Severe thrombocytopenia Expected problematic bleedingSpontaneous bleeding at <10 000
<25 000 Life-threatening condition Invasive procedures only at emergency andblood transfusion
Table 5. Platelet count and its effect on post-operative bleeding
They define hemostasis in the oral cavity as a multifactorial process, which is not well studied
yet. To a greater extent the insufficient use of lab tests may confound the appointed anticoa‐
gulation therapy and the risk for the patient could be greater than post-operative bleeding.
Meechan and Greenwood [76] propose that in cases of platelet count lower than 50*109/L an
urgent invasive procedure is needed. The latter could be performed after substitute platelet
transfusion 30 minutes before operation. In practice this approach is used quite rarely because
of the risk of immune sensitization. Patients on hemodialysis undergo heparinisation 3 times
a week before procedures, but heparin has a short half-life (around 5 hours), that’s why as a
precaution it’s accepted that it is best for any dental procedures to be performed on the day
after dialysis [30, 59]. On the other hand, the longer the time since the last dialysis, the greater
the chance for prolonged bleeding during invasive dental procedures because of uremia.
As a result of thrombocytic dysfunction, even with relatively good blood indicators, profuse
bleeding could be expected during invasive dental procedures [53, 80]. The treatment of these
patients requires a preventive strategy for oral and parodontal surgery that includes:
• the ability and the knowledge to perform atraumatic surgery;
• the use of sutures, compression bandages and local or systemic hemostatic agents. Assum‐
ing different reference books that propose different patterns for hemostasis and according
to Bulgarian experience in this direction, most frequently used medicaments are as follow:
Updates in Hemodialysis126
EAK, amp. 40% 20 ml I.v. very slow 1 amp.
Pamba, amp. 1% 5 ml I.m., I.v. 1–2 amp./24 h.
Vit. K, amp. 1% 1ml I.m, I.v.
Metadiol 5–10 mg oral/24 hours
Phytonadione 5–10 mg oral/24 hours
Tranexamic acid 10–12,5 mg/kg 2 times a day, p.o.
Desmopressin 03 mg/kg i.v. for 30 min single dose
Conjugated estrogen 0,6 mg/kg i.v. or 2,5–25 mg p.o. for 5 days
Cryoprecipitates are less frequently used because of the risk of disease transmission [40, 67, 80].
6. Post transplantation period (fig. 6)
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Figure 6. Schematic depiction of the post transplantation period
Dental treatment after transplantation can be differentiated in 3 periods - immediately after
transplantation to the 3rd month after transplantation, stable post-transplantation period, and
the period of chronic graft rejection [45, 67]. Diaz [54] defines the immediate after transplan‐
tation period till the 6th month following the operation.
Through the immediate period the possibility for post-operative complications, dominating
opportunistic virus and fungal infections, the risk of acute graft rejection is greater. Therefore
dental interference is not advisable, excluding any emergencies [53, 67, 82, 117].
Muzyka et al. [78] and J. B. Epstein [35] find that the most used antifungal agent in the initial
treatment plan of surface forms of oral candidiasis is Nystatin, applied locally as well as
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clotrimazole. Parenteral administration of Amphotericin B is associated with increased
nephrotoxicity, especially in combination with cyclosopin or aminoglycoside antibiotics. A
diluted parenteral solution of Amphotericin B for mouth rinse is successfully used in USA [15].
Ketoconazole is part of the imidazole group, but in combination with cyclosporine it may lead
to increased level of Cyclosporin A [32, 49, 99, 124].
The recommendations for dental treatment in the immediate after-transplantation period are
the following:
• Avoiding routine dental treatment, and if such is needed, conservative treatment methods
should be used;
• Meticulous oral hygiene that includes mouth rinse solutions containing chlorhexidine.
Djemileva [30] points out that the simultaneous use of toothpastes containing sodium
laurylsulfate may inactivate the chlorhexidine which is part of some mouth rinse solutions
and gels.
Dental rehabilitation of patients on hemodialysis and transplanted patients would be more
successful, if the methods of complex focal diagnostics and treatments are applied. They are
non-invasive and provide atraumatic and aseptic work techniques, combining thermal
diagnostics and a laser treatment approach.
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